Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Crown Holdings price target raised to $104 from $80 at Deutsche Bank » 07:11
10/22/20
10/22
07:11
10/22/20
07:11
CCK

Crown Holdings

$90.20 /

+3.06 (+3.51%)

Deutsche Bank analyst…

Deutsche Bank analyst Debbie Jones raised the firm's price target on Crown Holdings to $104 from $80 and keeps a Buy rating on the shares. The company reported an "impressive quarter ahead of expectations," Jones tells investors in a research note. The analyst thinks the stock will continue to attract growth investors willing to pay a higher multiple for the shares.

ShowHide Related Items >><<
CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

10/22/20 Morgan Stanley
Crown Holdings price target raised to $100 from $74 at Morgan Stanley
10/22/20 RBC Capital
Crown Holdings price target raised to $105 from $85 at RBC Capital
10/22/20 Citi
Crown Holdings price target raised to $103 from $94 at Citi
10/21/20 Baird
Crown Holdings price target raised to $105 from $80 at Baird
CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

Recommendations
Crown Holdings price target raised to $100 from $74 at Morgan Stanley » 06:52
10/22/20
10/22
06:52
10/22/20
06:52
CCK

Crown Holdings

$90.20 /

+3.06 (+3.51%)

Morgan Stanley analyst…

Morgan Stanley analyst Neel Kumar raised the firm's price target on Crown Holdings to $100 from $74 after the company's Q3 results came in "well above" consensus and its guidance was better than expected. Kumar, who said he anticipates another quarter of double-digit volume growth in North America, does not extrapolate the same level of Q3 operating earnings improvement to Q4 and keeps an Equal Weight rating on Crown shares.

ShowHide Related Items >><<
CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

10/22/20 RBC Capital
Crown Holdings price target raised to $105 from $85 at RBC Capital
10/22/20 Citi
Crown Holdings price target raised to $103 from $94 at Citi
10/21/20 Baird
Crown Holdings price target raised to $105 from $80 at Baird
10/21/20 JPMorgan
Crown Holdings price target raised to $104 from $85 at JPMorgan
CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

Recommendations
Crown Holdings price target raised to $105 from $85 at RBC Capital » 06:44
10/22/20
10/22
06:44
10/22/20
06:44
CCK

Crown Holdings

$90.20 /

+3.06 (+3.51%)

RBC Capital analyst Arun…

RBC Capital analyst Arun Viswanathan raised the firm's price target on Crown Holdings to $105 from $85 and keeps an Outperform rating on the shares. The analyst says the stock deserves a re-rating higher to trade near its closest peer because of "continued robust volume growth", rising demand for food cans, and an improved volume and sales mix profile that drives its margin expansion.

ShowHide Related Items >><<
CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

10/22/20 Citi
Crown Holdings price target raised to $103 from $94 at Citi
10/21/20 Baird
Crown Holdings price target raised to $105 from $80 at Baird
10/21/20 JPMorgan
Crown Holdings price target raised to $104 from $85 at JPMorgan
10/21/20 Wells Fargo
Crown Holdings price target raised to $100 from $87 at Wells Fargo
CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

Recommendations
Crown Holdings price target raised to $103 from $94 at Citi » 06:31
10/22/20
10/22
06:31
10/22/20
06:31
CCK

Crown Holdings

$90.20 /

+3.06 (+3.51%)

Citi analyst Anthony…

Citi analyst Anthony Pettinari raised the firm's price target on Crown Holdings to $103 from $94 and reiterates a Buy rating on the shares following the "strong" Q3 beat.

ShowHide Related Items >><<
CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

10/21/20 Baird
Crown Holdings price target raised to $105 from $80 at Baird
10/21/20 JPMorgan
Crown Holdings price target raised to $104 from $85 at JPMorgan
10/21/20 Wells Fargo
Crown Holdings price target raised to $100 from $87 at Wells Fargo
10/21/20 Barclays
Crown Holdings price target raised to $103 from $90 at Barclays
CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

CCK Crown Holdings
$90.20 /

+3.06 (+3.51%)

Recommendations
Crown Holdings price target raised to $105 from $80 at Baird » 08:46
10/21/20
10/21
08:46
10/21/20
08:46
CCK

Crown Holdings

$87.10 /

+4.935 (+6.01%)

Baird analyst Ghansham…

Baird analyst Ghansham Panjabi raised the firm's price target on Crown Holdings to $105 from $80 and keeps an Outperform rating on the shares. The analyst believes the shares remain undervalued as the abrupt consumption shift caused by at-home, end-market momentum remains strong, and good three-year visibility in the industry. He believes double digit earnings growth is possible through 2022.

ShowHide Related Items >><<
CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

10/21/20 JPMorgan
Crown Holdings price target raised to $104 from $85 at JPMorgan
10/21/20 Wells Fargo
Crown Holdings price target raised to $100 from $87 at Wells Fargo
10/21/20 Barclays
Crown Holdings price target raised to $103 from $90 at Barclays
10/16/20 Credit Suisse
Crown Holdings assumed with an Outperform at Credit Suisse
CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

Recommendations
Crown Holdings price target raised to $104 from $85 at JPMorgan » 08:41
10/21/20
10/21
08:41
10/21/20
08:41
CCK

Crown Holdings

$87.10 /

+4.935 (+6.01%)

, BLL

Ball Corp.

$91.40 /

+0.19 (+0.21%)

JPMorgan analyst Jeffrey…

JPMorgan analyst Jeffrey Zekauskas raised the firm's price target on Crown Holdings (CCK) to $104 from $85 and keeps an Overweight rating on the shares following the company's Q3 results. The analyst "significantly" raised earnings estimates saying the beverage can markets in the U.S. and Europe are characterized by tight supply/demand balances. Crown is exploring strategic alternatives given the large discount at which the shares trade relative to Ball Corporation (BLL), Zekauskas tells investors in a research note. If the analyst values Crown on a sum of the parts basis and places a three multiple point discount to Ball on the Crown beverage businesses, he gets to a $134 per share value.

ShowHide Related Items >><<
CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

BLL Ball Corp.
$91.40 /

+0.19 (+0.21%)

CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

10/21/20 Wells Fargo
Crown Holdings price target raised to $100 from $87 at Wells Fargo
10/21/20 Barclays
Crown Holdings price target raised to $103 from $90 at Barclays
10/16/20 Credit Suisse
Crown Holdings assumed with an Outperform at Credit Suisse
10/14/20 Seaport Global
Crown Holdings initiated with a Buy at Seaport Global
BLL Ball Corp.
$91.40 /

+0.19 (+0.21%)

10/16/20 Credit Suisse
Ball Corp. assumed with an Outperform at Credit Suisse
10/14/20 Seaport Global
Ball Corp. initiated with a Neutral at Seaport Global
10/08/20 Goldman Sachs
Ball Corp. price target raised to $91 from $80 at Goldman Sachs
10/08/20 BMO Capital
Ball Corp. upgraded to Outperform from Market Perform at BMO Capital
CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

BLL Ball Corp.
$91.40 /

+0.19 (+0.21%)

CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

BLL Ball Corp.
$91.40 /

+0.19 (+0.21%)

Recommendations
Crown Holdings price target raised to $100 from $87 at Wells Fargo » 08:14
10/21/20
10/21
08:14
10/21/20
08:14
CCK

Crown Holdings

$87.10 /

+4.935 (+6.01%)

Wells Fargo analyst Gabe…

Wells Fargo analyst Gabe Hajde raised the firm's price target on Crown Holdings to $100 from $87 and keeps an Overweight rating on the shares. The analyst views Crown Holdings as well positioned to monetize rapid growth in the North America beverage can demand, with a second half of 2020 recovery evident. Domestically, beverage can growth is surging as demand continues to outstrip supply over the near-term, Haide contends. Additionally, the analyst points out that beverage can demand in other regions showed a noticeable recovery in Q3 following a soft Q2. Lastly, the Transit Packaging business emerged from the Q2 trough with an improved cost structure and earnings, he adds.

ShowHide Related Items >><<
CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

10/21/20 Barclays
Crown Holdings price target raised to $103 from $90 at Barclays
10/16/20 Credit Suisse
Crown Holdings assumed with an Outperform at Credit Suisse
10/14/20 Seaport Global
Crown Holdings initiated with a Buy at Seaport Global
10/07/20 Jefferies
Crown Holdings price target raised to $90 from $82 at Jefferies
CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

Recommendations
Crown Holdings price target raised to $103 from $90 at Barclays » 06:33
10/21/20
10/21
06:33
10/21/20
06:33
CCK

Crown Holdings

$87.10 /

+4.935 (+6.01%)

Barclays analyst Michael…

Barclays analyst Michael Leithead raised the firm's price target on Crown Holdings to $103 from $90 and keeps an Overweight rating on the shares. While sentiment was bullish into the print, Crown delivered results exceeding expectations, "with little in the numbers to poke holes at," Leithead tells investors in a research note.

ShowHide Related Items >><<
CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

10/16/20 Credit Suisse
Crown Holdings assumed with an Outperform at Credit Suisse
10/14/20 Seaport Global
Crown Holdings initiated with a Buy at Seaport Global
10/07/20 Jefferies
Crown Holdings price target raised to $90 from $82 at Jefferies
09/18/20 JPMorgan
Crown Holdings price target raised to $85 from $81 at JPMorgan
CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

CCK Crown Holdings
$87.10 /

+4.935 (+6.01%)

On The Fly
Fly Intel: After-Hours Movers » 18:53
10/19/20
10/19
18:53
10/19/20
18:53
CCK

Crown Holdings

$82.17 /

-1.115 (-1.34%)

, ZION

Zions Bancorp

$30.22 /

-0.92 (-2.95%)

, ELS

Equity Lifestyle

$63.05 /

-0.88 (-1.38%)

, APTX

Aptinyx

$3.64 /

-0.1 (-2.67%)

, ACOR

Acorda Therapeutics

$0.69 /

+0.0214 (+3.19%)

, IVA

Inventiva

$14.70 /

+0.41 (+2.87%)

, ATEC

Alphatec

$9.88 /

-0.23 (-2.27%)

, SPNE

SeaSpine

$14.97 /

-0.42 (-2.73%)

, HXL

Hexcel

$36.30 /

+0.73 (+2.05%)

, IBM

IBM

$125.53 /

-0.4 (-0.32%)

, PPG

PPG

$134.67 /

-2.555 (-1.86%)

, PHR

Phreesia

$32.30 /

-0.43 (-1.31%)

, BLU

Bellus Health

$2.32 /

-0.07 (-2.94%)

Check out this evening's…

ShowHide Related Items >><<
ZION Zions Bancorp
$30.22 /

-0.92 (-2.95%)

SPNE SeaSpine
$14.97 /

-0.42 (-2.73%)

PPG PPG
$134.67 /

-2.555 (-1.86%)

PHR Phreesia
$32.30 /

-0.43 (-1.31%)

IVA Inventiva
$14.70 /

+0.41 (+2.87%)

IBM IBM
$125.53 /

-0.4 (-0.32%)

HXL Hexcel
$36.30 /

+0.73 (+2.05%)

CCK Crown Holdings
$82.17 /

-1.115 (-1.34%)

BLU Bellus Health
$2.32 /

-0.07 (-2.94%)

ATEC Alphatec
$9.88 /

-0.23 (-2.27%)

APTX Aptinyx
$3.64 /

-0.1 (-2.67%)

ACOR Acorda Therapeutics
$0.69 /

+0.0214 (+3.19%)

CCK Crown Holdings
$82.17 /

-1.115 (-1.34%)

10/16/20 Credit Suisse
Crown Holdings assumed with an Outperform at Credit Suisse
10/14/20 Seaport Global
Crown Holdings initiated with a Buy at Seaport Global
10/07/20 Jefferies
Crown Holdings price target raised to $90 from $82 at Jefferies
09/18/20 JPMorgan
Crown Holdings price target raised to $85 from $81 at JPMorgan
ZION Zions Bancorp
$30.22 /

-0.92 (-2.95%)

09/29/20 Truist
Truist raises price targets on select regional banks
07/31/20 Wolfe Research
Zions Bancorp initiated with an Underperform at Wolfe Research
07/21/20 Truist
Zions Bancorp price target lowered to $40 from $50 at SunTrust
06/30/20 Truist
SunTrust raises price targets across regional/community banks
ELS Equity Lifestyle
$63.05 /

-0.88 (-1.38%)

10/01/20 BMO Capital
Sun Communities price target raised to $165 from $160 at BMO Capital
10/01/20 Berenberg
Equity Lifestyle initiated with a Buy at Berenberg
07/22/20 Baird
Equity Lifestyle upgraded to Outperform from Neutral at Baird
03/30/20 Evercore ISI
Equity Lifestyle upgraded to Outperform from In Line at Evercore ISI
APTX Aptinyx
$3.64 /

-0.1 (-2.67%)

10/14/20 JPMorgan
Aptinyx resumed with a Neutral at JPMorgan
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
07/01/20 Truist
Aptinyx initiated with a Buy at SunTrust
05/08/20
Fly Intel: Top analyst initiations
ACOR Acorda Therapeutics
$0.69 /

+0.0214 (+3.19%)

10/24/19 JPMorgan
JPMorgan downgrades Acorda to Underweight on disappointing Inbrija launch
10/24/19 JPMorgan
Acorda Therapeutics downgraded to Underweight from Neutral at JPMorgan
IVA Inventiva
$14.70 /

+0.41 (+2.87%)

10/13/20 Roth Capital
Roth backs Buy on Inventiva after Lanifibranor given breakthrough designation
08/17/20 H.C. Wainwright
Inventiva price target raised to $38 from EUR 12 at H.C. Wainwright
08/05/20
Fly Intel: Top five analyst initiations
08/05/20 Roth Capital
Inventiva initiated with a Buy at Roth Capital
ATEC Alphatec
$9.88 /

-0.23 (-2.27%)

10/19/20 Stifel
Alphatec initiated with a Buy at Stifel
10/12/20 H.C. Wainwright
Alphatec price target raised to $12 from $9 at H.C. Wainwright
10/08/20 Lake Street
Alphatec price target raised to $15 from $13 at Lake Street
10/08/20 Canaccord
Alphatec price target raised to $12 from $9 at Canaccord
SPNE SeaSpine
$14.97 /

-0.42 (-2.73%)

10/19/20 Stifel
SeaSpine initiated with a Buy at Stifel
10/06/20 Piper Sandler
SeaSpine remains 'must-own SMID-cap name,' says Piper Sandler
08/05/20 Piper Sandler
SeaSpine remains 'must own SMID name' at Piper Sandler
06/16/20 Cantor Fitzgerald
SeaSpine assumed with an Overweight at Cantor Fitzgerald
HXL Hexcel
$36.30 /

+0.73 (+2.05%)

10/13/20 Wells Fargo
Hexcel price target lowered to $42 from $47 at Wells Fargo
10/09/20
Fly Intel: Top five analyst downgrades
10/09/20 Credit Suisse
Hexcel downgraded to Neutral from Outperform at Credit Suisse
09/25/20 Truist
Hexcel started with a Hold at Truist on commercial aero exposure
IBM IBM
$125.53 /

-0.4 (-0.32%)

10/09/20 Morgan Stanley
IBM price target raised to $140 from $128 at Morgan Stanley
09/22/20 UBS
IBM assumed with a Neutral at UBS
08/17/20 JPMorgan
IBM price target raised to $148 from $135 at JPMorgan
07/22/20 Argus
IBM upgraded to Buy from Hold at Argus
PPG PPG
$134.67 /

-2.555 (-1.86%)

10/19/20 Truist
Truist raises price targets in select Chemicals names
10/09/20 Deutsche Bank
PPG price target raised to $150 from $135 at Deutsche Bank
10/09/20 Citi
Westlake Chemical upgraded to Buy from Neutral at Citi
09/22/20 Evercore ISI
PPG initiated with an In Line at Evercore ISI
PHR Phreesia
$32.30 /

-0.43 (-1.31%)

09/22/20 DA Davidson
Phreesia initiated with a Buy at DA Davidson
09/22/20 DA Davidson
Phreesia initiated with a Buy at DA Davidson
09/09/20 Piper Sandler
Phreesia price target raised to $35 from $34 at Piper Sandler
07/14/20 Citi
Phreesia initiated with a Neutral at Citi
BLU Bellus Health
$2.32 /

-0.07 (-2.94%)

08/14/20 H.C. Wainwright
Bellus Health price target lowered to $10 from $28 at H.C. Wainwright
07/07/20 Guggenheim
Guggenheim downgrades Bellus Health to Neutral after 'disappointing' cough trial
07/07/20 Guggenheim
Bellus Health downgraded to Neutral from Buy at Guggenheim
07/06/20 Jefferies
Jefferies cuts Bellus target to $6, sees potential for 'meaningful upside'
ZION Zions Bancorp
$30.22 /

-0.92 (-2.95%)

SPNE SeaSpine
$14.97 /

-0.42 (-2.73%)

PPG PPG
$134.67 /

-2.555 (-1.86%)

PHR Phreesia
$32.30 /

-0.43 (-1.31%)

IBM IBM
$125.53 /

-0.4 (-0.32%)

HXL Hexcel
$36.30 /

+0.73 (+2.05%)

ELS Equity Lifestyle
$63.05 /

-0.88 (-1.38%)

CCK Crown Holdings
$82.17 /

-1.115 (-1.34%)

ATEC Alphatec
$9.88 /

-0.23 (-2.27%)

APTX Aptinyx
$3.64 /

-0.1 (-2.67%)

ACOR Acorda Therapeutics
$0.69 /

+0.0214 (+3.19%)

  • 21
    Oct
  • 20
    Oct
  • 14
    Oct
  • 10
    Jul
  • 10
    Jan
  • 08
    Jan
  • 13
    Dec
PPG PPG
$134.67 /

-2.555 (-1.86%)

IBM IBM
$125.53 /

-0.4 (-0.32%)

CCK Crown Holdings
$82.17 /

-1.115 (-1.34%)

PPG PPG
$134.67 /

-2.555 (-1.86%)

PHR Phreesia
$32.30 /

-0.43 (-1.31%)

IVA Inventiva
$14.70 /

+0.41 (+2.87%)

IBM IBM
$125.53 /

-0.4 (-0.32%)

HXL Hexcel
$36.30 /

+0.73 (+2.05%)

CCK Crown Holdings
$82.17 /

-1.115 (-1.34%)

BLU Bellus Health
$2.32 /

-0.07 (-2.94%)

ATEC Alphatec
$9.88 /

-0.23 (-2.27%)

ZION Zions Bancorp
$30.22 /

-0.92 (-2.95%)

PPG PPG
$134.67 /

-2.555 (-1.86%)

PHR Phreesia
$32.30 /

-0.43 (-1.31%)

IBM IBM
$125.53 /

-0.4 (-0.32%)

ACOR Acorda Therapeutics
$0.69 /

+0.0214 (+3.19%)

Hot Stocks
Crown Holdings up 5% to $86 after Q3 results, guidance top estimates  16:21
10/19/20
10/19
16:21
10/19/20
16:21
CCK

Crown Holdings

$82.17 /

-1.115 (-1.34%)

 
ShowHide Related Items >><<
CCK Crown Holdings
$82.17 /

-1.115 (-1.34%)

CCK Crown Holdings
$82.17 /

-1.115 (-1.34%)

10/16/20 Credit Suisse
Crown Holdings assumed with an Outperform at Credit Suisse
10/14/20 Seaport Global
Crown Holdings initiated with a Buy at Seaport Global
10/07/20 Jefferies
Crown Holdings price target raised to $90 from $82 at Jefferies
09/18/20 JPMorgan
Crown Holdings price target raised to $85 from $81 at JPMorgan
CCK Crown Holdings
$82.17 /

-1.115 (-1.34%)

CCK Crown Holdings
$82.17 /

-1.115 (-1.34%)

CCK Crown Holdings
$82.17 /

-1.115 (-1.34%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.